Korean J Infect Dis.  1998 Aug;30(4):379-384.

Sensitivity and Specificity of Vi-Indirect Fluore scent Antibody Test in Diagnosis of Typhoid Fever

Affiliations
  • 1Department of Internal Medicine, College of Medicine, Yonsei University, Seoul, Korea.
  • 2Department of Clinical Pathology, College of Medicine, Yonsei University, Seoul, Korea.

Abstract

BACKGROUND
Typhoid fever is diagnosed by culture or serological study. The confirmative diagnosis of typhoid fever is made by culture of the causative orga-nism usually from body fluids. Serological test is a supportive diagnostic tool, which is useful for early dia-gnosis. In Severance Hospital, Vi-indirect fluorescent antibody test(Vi-IFAT) using the Vi-antigen of Salmo-nella typhi has been used in the diagnosis of typhoid fever since 1989. We investigated the test results from the past 7 years, in order to clarify the sensitivity and specificity of Vi-IFAT.
METHODS
A retrospective study was done on pa-tients whose chief complaint was fever and who were tested using Vi-IFAT in the Severance Hospital from 1989 to 1996. The positive value for Vi-IFAT was de- fined as 1:64 or higher.
RESULTS
The sensitivity and specificity of Vi-IFAT for typhoid fever was 94.4% and 95.1%, respectively. The positive and negative predictive values were 85.7% and 98.2% respectively. Positive rates of Vi-IFAT after fever onset increased with time and 68% were positive before the first week. From the first to the second week, 89.5% were positive and after the second week, 100% were positive.
CONCLUSION
Vi-IFAT is not only a valuable sero-logic test for the diagnosis of typhoid fever, but also useful in the early diagnosis of the disease.

Keyword

Vi-antigen; Typhoid fever; Immunofluorescent antibody test

MeSH Terms

Body Fluids
Diagnosis*
Early Diagnosis
Fever
Retrospective Studies
Sensitivity and Specificity*
Serologic Tests
Typhoid Fever*
Full Text Links
  • KJID
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr